Site-specific CT imaging to quantify new HO volume showed a trend towards reduction with palovarotene treatment but did not meet statistical significance.
← all excerpts
Palovarotene (Sohonos), a synthetic retinoid for reducing new heterotopic ossification in fibrodysplasia ossificans progressiva: history, present, and future.
1
—
—